Skip to Main Content

Paper Details

Correction: Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-mediated DNA Damage Response.
Clin Cancer Res
1
2021
ATR, Glycogen Synthase Kinase-3, Pancreatic Cancer, Pancreatic Cancer Cells, TopBP1

Datasets